CRICUT INC - CLASS A (CRCT)

US22658D1000 - Common Stock

5.82  0 (0%)

After market: 5.82 0 (0%)

Fundamental Rating

6

Overall CRCT gets a fundamental rating of 6 out of 10. We evaluated CRCT against 66 industry peers in the Household Durables industry. While CRCT has a great health rating, its profitability is only average at the moment. CRCT has a decent growth rate and is not valued too expensively.



6

1. Profitability

1.1 Basic Checks

CRCT had positive earnings in the past year.
CRCT had a positive operating cash flow in the past year.
Each year in the past 5 years CRCT has been profitable.
CRCT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 9.37%, CRCT is doing good in the industry, outperforming 73.44% of the companies in the same industry.
Looking at the Return On Equity, with a value of 13.07%, CRCT is in line with its industry, outperforming 56.25% of the companies in the same industry.
CRCT's Return On Invested Capital of 12.72% is fine compared to the rest of the industry. CRCT outperforms 71.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRCT is in line with the industry average of 12.01%.
The last Return On Invested Capital (12.72%) for CRCT is above the 3 year average (12.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.37%
ROE 13.07%
ROIC 12.72%
ROA(3y)9.17%
ROA(5y)13.29%
ROE(3y)13.3%
ROE(5y)27.96%
ROIC(3y)12.7%
ROIC(5y)24.07%

1.3 Margins

CRCT's Profit Margin of 8.47% is fine compared to the rest of the industry. CRCT outperforms 67.19% of its industry peers.
CRCT's Profit Margin has declined in the last couple of years.
CRCT has a Operating Margin of 12.08%. This is in the better half of the industry: CRCT outperforms 70.31% of its industry peers.
CRCT's Operating Margin has declined in the last couple of years.
CRCT's Gross Margin of 48.45% is amongst the best of the industry. CRCT outperforms 90.63% of its industry peers.
In the last couple of years the Gross Margin of CRCT has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 8.47%
GM 48.45%
OM growth 3Y-20.65%
OM growth 5Y-2.11%
PM growth 3Y-24.24%
PM growth 5Y-13.54%
GM growth 3Y8.98%
GM growth 5Y6.53%

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRCT is creating some value.
CRCT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRCT has been reduced compared to 5 years ago.
There is no outstanding debt for CRCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 6.22 indicates that CRCT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.22, CRCT belongs to the top of the industry, outperforming 89.06% of the companies in the same industry.
There is no outstanding debt for CRCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.22
ROIC/WACC1.39
WACC9.16%

2.3 Liquidity

CRCT has a Current Ratio of 3.16. This indicates that CRCT is financially healthy and has no problem in meeting its short term obligations.
CRCT has a Current ratio (3.16) which is comparable to the rest of the industry.
CRCT has a Quick Ratio of 2.18. This indicates that CRCT is financially healthy and has no problem in meeting its short term obligations.
CRCT's Quick ratio of 2.18 is amongst the best of the industry. CRCT outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 2.18

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.67% over the past year.
The Earnings Per Share has been growing slightly by 2.10% on average over the past years.
CRCT shows a decrease in Revenue. In the last year, the revenue decreased by -9.85%.
The Revenue has been growing by 17.63% on average over the past years. This is quite good.
EPS 1Y (TTM)16.67%
EPS 3Y-29.61%
EPS 5Y2.1%
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y-7.25%
Revenue growth 5Y17.63%
Sales Q2Q%-4.01%

3.2 Future

CRCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.64% yearly.
The Revenue is expected to decrease by -2.10% on average over the next years.
EPS Next Y18.79%
EPS Next 2Y11.97%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue Next Year-8.03%
Revenue Next 2Y-4.26%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

5

4. Valuation

4.1 Price/Earnings Ratio

CRCT is valuated rather expensively with a Price/Earnings ratio of 20.79.
Compared to the rest of the industry, the Price/Earnings ratio of CRCT is on the same level as its industry peers.
CRCT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.34 indicates a rather expensive valuation of CRCT.
60.94% of the companies in the same industry are cheaper than CRCT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.99, CRCT is valued at the same level.
Industry RankSector Rank
PE 20.79
Fwd PE 19.34

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRCT is valued a bit cheaper than the industry average as 67.19% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRCT indicates a rather cheap valuation: CRCT is cheaper than 95.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.32
EV/EBITDA 7.54

4.3 Compensation for Growth

CRCT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CRCT may justify a higher PE ratio.
CRCT's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.11
PEG (5Y)9.89
EPS Next 2Y11.97%
EPS Next 3Y12.64%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.31%, CRCT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.95, CRCT pays a better dividend. On top of this CRCT pays more dividend than 90.63% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CRCT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

CRCT has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

0.53% of the earnings are spent on dividend by CRCT. This is a low number and sustainable payout ratio.
DP0.53%
EPS Next 2Y11.97%
EPS Next 3Y12.64%

CRICUT INC - CLASS A

NASDAQ:CRCT (12/24/2024, 2:20:00 PM)

After market: 5.82 0 (0%)

5.82

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners43.96%
Inst Owner Change-0.48%
Ins Owners13.51%
Ins Owner Change36.51%
Market Cap1.25B
Analysts44.44
Price Target5.14 (-11.68%)
Short Float %8.06%
Short Ratio10.41
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Dividend Growth(5Y)N/A
DP0.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-07 2025-01-07 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.44%
Min EPS beat(2)-0.47%
Max EPS beat(2)77.36%
EPS beat(4)2
Avg EPS beat(4)31.98%
Min EPS beat(4)-8.66%
Max EPS beat(4)77.36%
EPS beat(8)4
Avg EPS beat(8)11.13%
EPS beat(12)4
Avg EPS beat(12)-3.59%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-3.85%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-5.11%
Min Revenue beat(4)-9.2%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-4.33%
Revenue beat(12)2
Avg Revenue beat(12)-5.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.06%
PT rev (3m)-6.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.97%
EPS NY rev (1m)1.82%
EPS NY rev (3m)2.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.43%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-2.23%
Valuation
Industry RankSector Rank
PE 20.79
Fwd PE 19.34
P/S 1.7
P/FCF 5.32
P/OCF 4.91
P/B 2.62
P/tB 2.62
EV/EBITDA 7.54
EPS(TTM)0.28
EY4.81%
EPS(NY)0.3
Fwd EY5.17%
FCF(TTM)1.09
FCFY18.81%
OCF(TTM)1.18
OCFY20.35%
SpS3.42
BVpS2.22
TBVpS2.22
PEG (NY)1.11
PEG (5Y)9.89
Profitability
Industry RankSector Rank
ROA 9.37%
ROE 13.07%
ROCE 18.01%
ROIC 12.72%
ROICexc 25.52%
ROICexgc 25.52%
OM 12.08%
PM (TTM) 8.47%
GM 48.45%
FCFM 31.96%
ROA(3y)9.17%
ROA(5y)13.29%
ROE(3y)13.3%
ROE(5y)27.96%
ROIC(3y)12.7%
ROIC(5y)24.07%
ROICexc(3y)20.95%
ROICexc(5y)42.27%
ROICexgc(3y)20.99%
ROICexgc(5y)42.9%
ROCE(3y)17.98%
ROCE(5y)35.5%
ROICexcg growth 3Y-47.75%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y-47.39%
ROICexc growth 5Y-4.9%
OM growth 3Y-20.65%
OM growth 5Y-2.11%
PM growth 3Y-24.24%
PM growth 5Y-13.54%
GM growth 3Y8.98%
GM growth 5Y6.53%
F-Score7
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 63.67%
Cap/Sales 2.62%
Interest Coverage 250
Cash Conversion 213.52%
Profit Quality 377.42%
Current Ratio 3.16
Quick Ratio 2.18
Altman-Z 6.22
F-Score7
WACC9.16%
ROIC/WACC1.39
Cap/Depr(3y)129.56%
Cap/Depr(5y)139.31%
Cap/Sales(3y)3.22%
Cap/Sales(5y)2.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y-29.61%
EPS 5Y2.1%
EPS Q2Q%-37.5%
EPS Next Y18.79%
EPS Next 2Y11.97%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y-7.25%
Revenue growth 5Y17.63%
Sales Q2Q%-4.01%
Revenue Next Year-8.03%
Revenue Next 2Y-4.26%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A
EBIT growth 1Y31.41%
EBIT growth 3Y-26.4%
EBIT growth 5Y15.14%
EBIT Next Year73.11%
EBIT Next 3Y25.28%
EBIT Next 5YN/A
FCF growth 1Y3501.78%
FCF growth 3Y5.31%
FCF growth 5YN/A
OCF growth 1Y823.57%
OCF growth 3Y5.09%
OCF growth 5YN/A